Delisted from NASDAQ in Sep 2023
Company logo

CFMS - Conformis, Inc.

NASDAQ -> Healthcare -> Medical Devices
Billerica, United States
Type: Equity

CFMS price evolution
CFMS
(in millions $) 30 Jun 2023 31 Mar 2023 31 Jan 2023 30 Oct 2022
Current assets
Cash $26.64 $38.25 $49.13 $60.04
Short term investments
Net receivables $7.8 $8.67 $9.91 $9.61
Inventory $19.02 $19.49 $18.91 $18.02
Total current assets $54.62 $67.62 $79.27 $88.81
Long term investments
Property, plant & equipment $12.61 $13.76 $14.23 $15.24
Goodwill & intangible assets
Total noncurrent assets $13.16 $14.3 $14.78 $15.79
Total investments
Total assets $67.78 $81.92 $94.05 $104.59
Current liabilities
Accounts payable $3.58 $4.16 $4.16 $6.56
Deferred revenue
Short long term debt $1.94 $1.95 $1.93 $1.92
Total current liabilities $10.77 $11.84 $14.07 $17.52
Long term debt $24.65 $25.17 $20.56 $25.91
Total noncurrent liabilities $24.98 $25.46 $25.8 $25.91
Total debt $26.58 $27.13 $27.5 $27.83
Total liabilities $35.76 $37.3 $39.87 $43.43
Shareholders' equity
Retained earnings -$603.91 -$590.89 -$581.32 -$577.61
Other shareholder equity $0.23 $0.25 $0.86 $3.88
Total shareholder equity $32.02 $44.63 $54.18 $61.16
(in millions $) 31 Jan 2023 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $49.13 $101.12 $29.14 $26.86
Short term investments
Net receivables $9.91 $9.36 $9.77 $11.23
Inventory $18.91 $15.2 $12.59 $12.07
Total current assets $79.27 $126.88 $53.34 $52.51
Long term investments
Property, plant & equipment $14.23 $17.8 $17.45 $19.21
Goodwill & intangible assets
Total noncurrent assets $14.78 $18.46 $18.16 $19.88
Total investments
Total assets $94.05 $145.34 $71.5 $72.4
Current liabilities
Accounts payable $4.16 $6.56 $4.92 $6.92
Deferred revenue
Short long term debt $1.93 $1.83 $1.62 $1.47
Total current liabilities $14.07 $17.96 $30.92 $17.86
Long term debt $20.56 $26.83 $29.21 $24.69
Total noncurrent liabilities $25.8 $26.83 $29.21 $38.19
Total debt $27.5 $28.66 $30.83 $26.16
Total liabilities $39.87 $44.79 $60.13 $56.05
Shareholders' equity
Retained earnings -$581.32 -$530.85 -$528.44 -$504.14
Other shareholder equity $0.86 -$1.11 -$4 -$0.86
Total shareholder equity $54.18 $100.55 $11.37 $16.35
(in millions $) 30 Jun 2023 31 Mar 2023 31 Dec 2022 30 Oct 2022
Revenue
Total revenue $13.02 $12.84 $17.42
Cost of revenue $11.19 $7.73 $10.27
Gross Profit $1.83 $5.1 $7.16
Operating activities
Research & development $2.16 $2.46 $3.23
Selling, general & administrative $11.98 $12.07 $10.73
Total operating expenses $14.14 $14.53 $13.96
Operating income -$12.3 -$9.43 -$6.8
Income from continuing operations
EBIT -$12.31 -$8.95 -$3.11
Income tax expense $0.03 -$0.02 $0.02
Interest expense $0.67 $0.64 $0.59
Net income
Net income -$13.01 -$9.57 -$3.72
Income (for common shares) -$13.01 -$9.57 -$3.72
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $62.05 $99.86 $68.76 $77.43
Cost of revenue $38.84 $34.18 $35.05 $40.69
Gross Profit $23.21 $65.68 $33.72 $36.74
Operating activities
Research & development $15.34 $14.79 $11.94 $12.46
Selling, general & administrative $54.15 $53.9 $46.89 $49.41
Total operating expenses $69.49 $68.69 $58.83 $61.87
Operating income -$46.28 -$3.01 -$25.11 -$25.13
Income from continuing operations
EBIT -$48.48 $1.17 -$21.88 -$25.49
Income tax expense -$0.02 $0.09 $0.04 $0.04
Interest expense $2.02 $3.5 $2.37 $2.94
Net income
Net income -$50.47 -$2.41 -$24.29 -$28.48
Income (for common shares) -$50.47 -$2.41 -$24.29 -$28.48
(in millions $) 30 Jun 2023 31 Mar 2023 31 Dec 2022 30 Sep 2022
Net income -$13.01 -$9.57 -$3.72 -$15.2
Operating activities
Depreciation $1.31 $1.3 $1.33 $1.34
Business acquisitions & disposals
Stock-based compensation $0.43 $0.62 -$0.25 $0.8
Total cash flows from operations -$11.29 -$9.85 -$11.36 -$12.03
Investing activities
Capital expenditures -$0.31 -$0.91 -$0.32 -$0.61
Investments
Total cash flows from investing -$0.31 -$0.91 -$0.32 -$0.61
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing
Effect of exchange rate -$0.01 -$0.13 $0.77 -$0.42
Change in cash and equivalents -$11.6 -$10.88 -$10.91 -$13.06
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$50.47 -$2.41 -$24.29 -$28.48
Operating activities
Depreciation $5.55 $5.72 $5.55 $5.38
Business acquisitions & disposals
Stock-based compensation $2.13 $3.81 $3.41 $2.84
Total cash flows from operations -$50.15 -$8.4 -$18.31 -$2.84
Investing activities
Capital expenditures -$1.92 -$2.3 -$3.25 -$2.93
Investments $7.25
Total cash flows from investing -$1.92 -$2.3 -$3.25 $4.32
Financing activities
Dividends paid
Sale and purchase of stock $84.89 $19.05 $5.18
Net borrowings -$0.87 $4.71 $4.26
Total cash flows from financing $82.8 $23.76 $8.53
Effect of exchange rate $0.08 -$0.12 $0.08 $0
Change in cash and equivalents -$51.99 $71.98 $2.28 $10.01
Fundamentals
Market cap $17.81M
Enterprise value $17.75M
Shares outstanding 7.88M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q -14.85%
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 0.56
Book/Share 4.04
Cash/Share 3.38
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.74
Net debt/EBITDA N/A
Current ratio 5.07
Quick ratio 3.30